These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

269 related articles for article (PubMed ID: 18621920)

  • 1. Anti-inflammatory apoA-I-mimetic peptides bind oxidized lipids with much higher affinity than human apoA-I.
    Van Lenten BJ; Wagner AC; Jung CL; Ruchala P; Waring AJ; Lehrer RI; Watson AD; Hama S; Navab M; Anantharamaiah GM; Fogelman AM
    J Lipid Res; 2008 Nov; 49(11):2302-11. PubMed ID: 18621920
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Apolipoprotein A-I mimetic peptide helix number and helix linker influence potentially anti-atherogenic properties.
    Wool GD; Reardon CA; Getz GS
    J Lipid Res; 2008 Jun; 49(6):1268-83. PubMed ID: 18323574
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein A-I mimetic 4F alters the function of human monocyte-derived macrophages.
    Smythies LE; White CR; Maheshwari A; Palgunachari MN; Anantharamaiah GM; Chaddha M; Kurundkar AR; Datta G
    Am J Physiol Cell Physiol; 2010 Jun; 298(6):C1538-48. PubMed ID: 20219948
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of increasing hydrophobicity on the physical-chemical and biological properties of a class A amphipathic helical peptide.
    Datta G; Chaddha M; Hama S; Navab M; Fogelman AM; Garber DW; Mishra VK; Epand RM; Epand RF; Lund-Katz S; Phillips MC; Segrest JP; Anantharamaiah GM
    J Lipid Res; 2001 Jul; 42(7):1096-104. PubMed ID: 11441137
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aromatic residue position on the nonpolar face of class a amphipathic helical peptides determines biological activity.
    Datta G; Epand RF; Epand RM; Chaddha M; Kirksey MA; Garber DW; Lund-Katz S; Phillips MC; Hama S; Navab M; Fogelman AM; Palgunachari MN; Segrest JP; Anantharamaiah GM
    J Biol Chem; 2004 Jun; 279(25):26509-17. PubMed ID: 15075321
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An apoA-I mimetic peptide containing a proline residue has greater in vivo HDL binding and anti-inflammatory ability than the 4F peptide.
    Wool GD; Vaisar T; Reardon CA; Getz GS
    J Lipid Res; 2009 Sep; 50(9):1889-900. PubMed ID: 19433476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apolipoprotein A-I mimetic peptides.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Yu N; Ansell BJ; Datta G; Garber DW; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2005 Jul; 25(7):1325-31. PubMed ID: 15831812
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Carboxyl-Terminal Cleavage of Apolipoprotein A-I by Human Mast Cell Chymase Impairs Its Anti-Inflammatory Properties.
    Nguyen SD; Maaninka K; Lappalainen J; Nurmi K; Metso J; Öörni K; Navab M; Fogelman AM; Jauhiainen M; Lee-Rueckert M; Kovanen PT
    Arterioscler Thromb Vasc Biol; 2016 Feb; 36(2):274-84. PubMed ID: 26681753
    [TBL] [Abstract][Full Text] [Related]  

  • 9. L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
    Sharifov OF; Xu X; Gaggar A; Tabengwa EM; White CR; Palgunachari MN; Anantharamaiah GM; Gupta H
    Inflammation; 2014 Oct; 37(5):1401-12. PubMed ID: 24647607
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro stimulation of HDL anti-inflammatory activity and inhibition of LDL pro-inflammatory activity in the plasma of patients with end-stage renal disease by an apoA-1 mimetic peptide.
    Vaziri ND; Moradi H; Pahl MV; Fogelman AM; Navab M
    Kidney Int; 2009 Aug; 76(4):437-44. PubMed ID: 19471321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enhancement by LDL of transfer of L-4F and oxidized lipids to HDL in C57BL/6J mice and human plasma.
    Meriwether D; Imaizumi S; Grijalva V; Hough G; Vakili L; Anantharamaiah GM; Farias-Eisner R; Navab M; Fogelman AM; Reddy ST; Shechter I
    J Lipid Res; 2011 Oct; 52(10):1795-809. PubMed ID: 21804067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human apolipoprotein A-I and A-I mimetic peptides: potential for atherosclerosis reversal.
    Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Datta G; Garber D; Fogelman AM
    Curr Opin Lipidol; 2004 Dec; 15(6):645-9. PubMed ID: 15529023
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Apolipoprotein A-I mimetic peptides: a potential new therapy for the prevention of atherosclerosis.
    Sherman CB; Peterson SJ; Frishman WH
    Cardiol Rev; 2010; 18(3):141-7. PubMed ID: 20395699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oxpholipin 11D: an anti-inflammatory peptide that binds cholesterol and oxidized phospholipids.
    Ruchala P; Navab M; Jung CL; Hama-Levy S; Micewicz ED; Luong H; Reyles JE; Sharma S; Waring AJ; Fogelman AM; Lehrer RI
    PLoS One; 2010 Apr; 5(4):e10181. PubMed ID: 20418958
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lipid complex of apolipoprotein A-I mimetic peptide 4F is a novel platform for paraoxonase-1 binding and enhancing its activity and stability.
    Mishra VK; Palgunachari MN; McPherson DT; Anantharamaiah GM
    Biochem Biophys Res Commun; 2013 Jan; 430(3):975-80. PubMed ID: 23261466
    [TBL] [Abstract][Full Text] [Related]  

  • 16. ApoA-I mimetic peptides with differing ability to inhibit atherosclerosis also exhibit differences in their interactions with membrane bilayers.
    Handattu SP; Garber DW; Horn DC; Hughes DW; Berno B; Bain AD; Mishra VK; Palgunachari MN; Datta G; Anantharamaiah GM; Epand RM
    J Biol Chem; 2007 Jan; 282(3):1980-8. PubMed ID: 17114186
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effect of HDL mimetic peptide 4F on PON1.
    Vakili L; Hama S; Kim JB; Tien D; Safarpoor S; Ly N; Vakili G; Hough G; Navab M
    Adv Exp Med Biol; 2010; 660():167-72. PubMed ID: 20221879
    [TBL] [Abstract][Full Text] [Related]  

  • 18. D-4F, an apolipoprotein A-I mimetic peptide, inhibits the inflammatory response induced by influenza A infection of human type II pneumocytes.
    Van Lenten BJ; Wagner AC; Navab M; Anantharamaiah GM; Hui EK; Nayak DP; Fogelman AM
    Circulation; 2004 Nov; 110(20):3252-8. PubMed ID: 15533864
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Apolipoprotein A-I mimetic peptides and their role in atherosclerosis prevention.
    Navab M; Anantharamaiah GM; Reddy ST; Fogelman AM
    Nat Clin Pract Cardiovasc Med; 2006 Oct; 3(10):540-7. PubMed ID: 16990839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Normal high density lipoprotein inhibits three steps in the formation of mildly oxidized low density lipoprotein: steps 2 and 3.
    Navab M; Hama SY; Anantharamaiah GM; Hassan K; Hough GP; Watson AD; Reddy ST; Sevanian A; Fonarow GC; Fogelman AM
    J Lipid Res; 2000 Sep; 41(9):1495-508. PubMed ID: 10974057
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.